Clinical Trial: A Real-world Study About the Impact of Siponimod Treatment on Secondary Progressive Multiple Sclerosis Patients in Russia

U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07168694) titled 'A Real-world Study About the Impact of Siponimod Treatment on Secondary Progressive Multiple Sclerosis Patients in Russia' on Sept. 04.

Brief Summary: The main aim of the study was to describe the demographic and clinical characteristics of patients with secondary progressive multiple sclerosis (SPMS) who were receiving siponimod therapy in Russia. This study analyzed data from outpatient records/medical records collected across 11 Russian multiple sclerosis (MS) centers. Data collection was carried out from April 16, 2024 to September 26, 2024.

Study Start Date: April 16, 2024

Study Type: OBSERVATIONAL

Condition: Secondary Pro...